Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Hormone Therapy Market Through 2029?

In recent times, the market size for hormone therapy has significantly expanded. There is an expected growth from $19.7 billion in 2024 to $20.9 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Medical improvements, evolution in women’s health, heightened awareness and education, clinical investigations and developments, as well as alterations in healthcare practices have all contributed to the growth experienced in the historic period.

Expectations are set for the hormone therapy market size to experience robust growth in the ensuing years, reaching $27.83 billion in 2029 with a compound annual growth rate (CAGR) of 7.4%. The projected growth during this period can be attributed to various factors, such as the approach to personalized medicine, the dynamics of an aging population, alterations in women’s health strategies, emphasis on wellness and longevity, along with regulatory adaptations. Significant trends of the forecast period encompass changes in regulations and guidelines, evolving lifestyles coupled with stress, advanced research and development, as well as growing awareness and education.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9246&type=smp

What Market Forces Are Driving The Hormone Therapy Sector In 2025 And Beyond?

The hormone therapy market’s advancement is primarily being driven by a growing number of hormone imbalance disorders. Hormone imbalance is a condition characterized by the body’s overproduction or underproduction of certain hormones. These disorders could include hypothyroidism, hypogonadism, and growth hormone deficiency, amongst others. There are several hormone therapies employed to combat these imbalances, inclusive of estrogen replacement, testosterone replacement, and insulin therapy. For instance, a study published by the London Medical Laboratory, a UK-based diagnostic and phlebotomy institution, predicted a 19% increase in substantial hormone imbalances in 2022 as compared to two years prior. Consequently, this increasing prevalence of hormone imbalance disorders is propelling the growth of the hormone therapy market.

How Is The Global Hormone Therapy Market Categorized By Segments?

The hormone therapy market covered in this report is segmented –

1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy

2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones

3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid

4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets

What Long-Term Trends Are Likely To Affect The Hormone Therapy Market?

Key players in the hormone therapy market are prioritizing the creation of innovative strategies such as the direct-to-consumer telehealth models for hormone therapy, with the aim to improve accessibility and convenience. The particular model permits patients to avail of hormone therapy services from a distance, eliminating the requirement for conventional face-to-face meetings. For example, LifeMD, a telehealth firm based in the US, collaborated with ASCEND Therapeutics, a US pharmaceutical company, in September 2023 to establish a consolidated direct-to-consumer telehealth model for hormone therapy, concentrating particularly on EstroGel to relieve menopausal symptoms. This collaboration enables patients to directly utilize LifeMD’s telehealth services via the EstroGel website, providing consultations with authorized healthcare professionals who can prescribe the drug and organize home delivery. By improving access and overcoming challenges such as extensive waiting times, this initiative strives to improve health results for women seeking treatment for menopause.

Which Firms Are Considered Leaders In The Hormone Therapy Market Space?

Major companies operating in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy’s Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

What Role Do Regional Policies And Investments Play In Hormone Therapy Market Expansion?

North America was the largest region in the hormone therapy market in 2024. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9246&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model